bioMerieux Japan

BioMerieux designs, develops, manufactures, and sells in vitro diagnostic systems for clinical and industrial applications.The company's diagnostic systems include reagents and consumables for conducting biological tests used in screening, diagnostic assistance, prognosis, and therapeutic monitoring; instruments, platforms, and automated analyzers for high-throughput or low-throughput automated testing; software for processing analyses and systems to interpret biological test results; and other related services such as instrument installation and maintenance, user training, and laboratory workflow audits. BioMerieux provides diagnostic systems for clinical applications, including the analysis of biological samples such as blood, saliva, and urine to diagnose infectious diseases, including HIV, tuberculosis, and respiratory illnesses, as well as cardiovascular diseases and targeted cancers; and for industrial applications, including microbial manufacturing analysis for food, pharmaceuticals, and cosmetics. The company markets and sells its products through a distributor network to private-sector analytical laboratories, hospital laboratories, blood banks, and physician office laboratories; the food, pharmaceutical, and cosmetics industries; and independent quality control laboratories. It operates in Europe, the Middle East, Africa, North America, the Asia-Pacific region, and Latin America.